title: Green tea drinking improves erythrocytes and saliva oxidative status in the elderly.
abstract: We have previously shown that green tea (GT) drinking combined with vitamin E supplementation reduced plasma protein carbonyls and increased erythrocytes catalase activity in exercising healthy elderly. In the present study we set out to investigate the antioxidative effects of GT drinking in an aging population. We performed an interventional, crossover, controlled prospective trial with 35 healthy elderly subjects (mean age 67.3±4.8 years), supplemented with four daily placebo maltodextrin "tea-bags" for 12 weeks, followed by four 1.5 g daily GT bags for another 12 weeks. Data were obtained at baseline, at the end of the placebo period, and at the end of the GT intervention period. We found that GT did not alter erythrocyte catalase activity. However, it provided protection against 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced oxidative hemolysis which declined by 10.2% (p<0.001). No changes were observed in saliva oral peroxidase enzymes. Nonetheless, saliva total antioxidant capacity increased by 42.0% (p<0.01). Plasma oxidative products, such as protein carbonyls, lipid peroxides and thiobarbituric acid reactive substances (TBARS) were stable throughout the intervention period. We conclude that four daily cups of GT are well tolerated in elderly free living subjects. Our results demonstrate that both erythrocyte resistances to oxidation and saliva antioxidant capacity are improved by GT drinking. The clinical implications of these oxidation modifications require further research.
authors.affiliation: Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
authors.forename: B
authors.initials: B
authors.lastname: Narotzki
authors.forename: A Z
authors.initials: AZ
authors.lastname: Reznick
authors.forename: T
authors.initials: T
authors.lastname: Mitki
authors.forename: D
authors.initials: D
authors.lastname: Aizenbud
authors.forename: Y
authors.initials: Y
authors.lastname: Levy
mesh_terms: D000368:Aged; D000375:Aging / Q000097:blood*; D000578:Amidines / Q000494:pharmacology; D000975:Antioxidants / Q000378:metabolism*; D002478:Cells, Cultured; D018592:Cross-Over Studies; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008875:Middle Aged; D016877:Oxidants / Q000494:pharmacology; D010084:Oxidation-Reduction; D010544:Peroxidases / Q000378:metabolism; D011446:Prospective Studies; D050050:Protein Carbonylation; D012463:Saliva / Q000737:chemistry*; D013662:Tea; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
chemical_list: D000578:Amidines; D000975:Antioxidants; D016877:Oxidants; D013662:Tea; D017392:Thiobarbituric Acid Reactive Substances; C046728:2,2'-azobis(2-amidinopropane); D010544:Peroxidases